DeutschNewstral
Chad Robins
Seattle brothers expand billion-dollar biotech company’s focus to include COVIDSeattle Times
T-cell screening launched to detect previous coronavirus infections - Wed, 24 Feb 2021 PSTThe Spokesman-Review
How Moderna execs are cashing in during the race to develop COVID-19 vaccineThe Japan Times
Big Pharma executives are cashing in as COVID-19 vaccine race sends shares surgingSydney Morning Herald- MHow to invest for income when bonds pay pennies on the dollarmarketwatch.com
- MAdaptive Biotechnologies CEO Chad Robins on that crazy IPO and working with his older brothermarketwatch.com
- MAdaptive Biotechnologies IPO: Five things to knowmarketwatch.com
- Adaptive Biotech seeks $230 million in IPOSeattle Times
Seattle biotech Adaptive lives up to its name, pivots toward drug developmentbizjournals.com
Adaptive Biotech hires CFO who helped Zilllow go publicseattletimes.com- This man took Zillow public. Is Adaptive Biotechnologies next?bizjournals.com
- Former Zillow CFO heads to Seattle biotechbizjournals.com
- Adaptive Biotechnologies set to open New York City officebizjournals.com
- One year, nearly $400M and a plan to improve drug testing: This Seattle biotech is roaringbizjournals.com
- Adaptive Biotechnologies raises $195 million in venture fundingseattletimes.com
- Seattle biotech Adaptive buys San Francisco firmseattletimes.com
- Adaptive Bio raises $94 million, buys Bay Area's Sequentabizjournals.com
Frequent names
Newstral's extraction of names of people and organisations from the world's news is completely automated. If you do not want your name to appear here, please contact us. We will be happy to look at your request.